Cancer Biology Faculty

Faculty, Lecturers and Instructors

Many DKFZ laboratories are incorporated into our innovative Major "Cancer Biology" Program. This allows the students to experience cutting edge science and to interact with internationally leading scientists at a very early stage of their career.

 

The lists of lecturers and instructors from the various Research Divisions and Groups, who  are actively involved in the Major Cancer Biology study program, are arranged according to the DKFZ Research Programs (Forschungsschwerpunkte):

Prof. Dr. Peter ANGEL, Division of Signal Transduction and Growth Control (A100) E-mail


Prof. Dr. Hellmut AUGUSTIN, Division of Vascular Oncology and Metastasis (A190) E-mail

Dr. Felix BORMANN, Division of Epigenetics (A130) E-mail

Prof. Dr. Petra BOUKAMP, formerly: Division of Genetics of Skin Carcinogenesis E-mail

PD Dr. Tobias DICK, Division of Redox Regulation (A160) E-mail

Dr. Marieke ESSERS, HI-STEM Junior Research Group Stress-induced Activation of Hematopoietic Stem Cells (A011) E-mail

Dr. Cassandra FALCKENHAYN, Division of Epigenetics (A130) E-mail

PD Dr. Andreas FISCHER, Helmholtz University Junior Research Group Vascular Signaling and Cancer (A270E-mail

Dr. Karin GREULICH-BODE, formerly: Division of Genetics of Skin Carcinogenesis E-mail

Prof. Dr. Ilse HOFMANN, Division of Vascular Oncology and Metastasis (A190E-mail

Dr. Susanne KLEBER, Division of Molecular Neurobiology (A290) E-mail

Prof. Dr. Michael KNOP, Research Group Cell Morphogenesis and Signal Transduction (A260) and ZMBH E-mail

Dr. Hai-Kun LIU, Division of Molecular Neurogenetics (A240) E-mail

Prof. Dr. Frank LYKO, Division of Epigenetics (A130) E-mail

Prof. Dr. Ana MARTIN-VILLALBA, Division of Molecular Neurobiology (A290) E-mail

Dr. Michael MILSOM, HI-STEM Junior Research Group Experimental Hematology (A012) E-mail

PD Dr. Karin MÜLLER-DECKER, Core Facility Tumor Models (W420), E-mail

Dr. Thordur OSKARSSON, HI-STEM Junior Research Group Metastatic Niches (A014) E-mail

PD Dr. Marina SCHORPP-KISTNER, Division of Signal Transduction and Growth Control (A100) E-mail

Prof. Dr. Georg STOECKLIN, RNA Translation and Turnover Lab, CBTM Mannheim and ZMBHE-mail

Prof. Dr. Andreas TRUMPP, Division of Stem Cells and Cancer (A010) and HI-STEM E-mail

Dr. Alexandros VEGIOPOULOS, DKFZ Junior Group Metabolism and Stem Cell Plasticity (A171) E-mail

PD Dr. Renate VOIT, Helmholtz Professor Group Molecular Biology of the Cell II (A030) E-mail

Dr. Iris AUGUSTIN, Division Signaling and Functional Genomics (B110) E-mail


Dr. Andrea BAUER, Division of Functional Genome Analysis (B070) E-mail

Prof. Dr. Michael BOUTROS, Division Signaling and Functional Genomics (B110) E-mail

Dr. Lorenza D'ALESSANDRO, Division of Systems Biology of Signal Transduction (B200) E-mail

Prof. Dr. Sven DIEDERICHS. Division of RNA Biology and Cancer (B150) E-mail

Dr. Bernd FISCHER, Junior Research Group Computational Genome Biology (B210) E-mail

Dr. Violaine GOIDTS, DKFZ Junior Group Brain Tumor Translational Targets (B067) E-mail

Dr. Jörg HOHEISEL, Division of Functional Genome Analysis (B070) E-mail

PD Dr. Sabine KLAUCK, Research Group Cancer Genome Research (B063) E-mail

Prof. Dr. Ursula KLINGMÜLLER, Division of Systems Biology of Signal Transduction (B200) E-mail

Dr. Cindy KÖRNER, Division of Molecular Genome Analysis (B050) E-mail

Prof. Dr. Jeroen KRIJGSVELD, Division of Proteomics of Stem Cells and Cancer (B230) E-mail

Prof. Dr. Jörg LANGOWSKI, Division of Biophysics of Macromolecules (B040) E-mail

Prof. Dr. Peter LICHTER, Division of Molecular Genetics (B060) E-mail

Dr. Norbert MÜCKE, Division of Biophysics of Macromolecules (B040) Contact Form

Dr. Fillip PORT, Division Signaling and Functional Genomics (B110) E-mail

Dr. Marcel SCHILLING, Division of Systems Biology of Signal Transduction (B200) E-mail

Prof. Dr. Rocio SOTILLO, Division of Molecular Thoracic Oncology (B220) E-mail

Prof. Dr. Holger SÜLTMANN, Research Group Cancer Genome Research (B063) and NCT E-mail

Prof. Dr. Aurelio TELEMAN, Division of Signal Transduction in Cancer and Metabolism (B140) E-mail

Dr. Katalin TOTH, Division of Biophysics of Macromolecules (B040) E-mail

Dr. Oksana VOLOSHANENKO, Division Signaling and Functional Genomics (B110) E-mail

PD Dr. Frank WESTERMANN, Research Group Neuroblastoma Genomics (B087) E-mail

Prof. Dr. Stefan WIEMANN, Division of Molecular Genome Analysis (B050) E-mail

Dr. Annika BAUDE, Division of Epigenomics and Cancer Risk Factors (C010) E-mail


Dr. Michael DASKALAKIS, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

Dr. Clarissa GERHÄUSER, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

Prof. Dr. Rudolf KAAKS, Division of Cancer Epidemiology (C020) E-mail

Prof. Dr. Rajiv KUMAR, Division of Molecular Genetic Epidemiology (C050) E-mail

Dr. Daniel LIPKA, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

Prof. Dr. Justo LORENZO BERMEJO, Institute of Medical Biometry and Informatics (IMBI), University Hospital Heidelberg E-mail

Dr. Simin ÖZ, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

Prof. Dr. Christoph PLASS, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

PD Dr. Odilia POPANDA, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

Dr. Peter SCHMEZER, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

Dr. Dieter WEICHENHAN, Division of Epigenomics and Cancer Risk Factors (C010) E-mail

PD Dr. Rüdiger ARNOLD, formerly: Division of Immunogenetics and Heidelberger Life Science Lab

Dr. Christian BUSSE, Division of B Cell Immunology (D130) E-mail

PD Dr. Adelheid CERWENKA, Boveri Junior Research Group Innate Immunity (D080) E-mail

Dr. Angel CID-ARREGUI, VLP Project Group, Division of Translational Immunology (D015) E-mail

Dr. Margareta CORREIA, Boveri Junior Research Group Innate Immunity (D080) E-mail

Prof. Dr. Stefan EICHMÜLLER: now with Research Program 'G'

Dr. Markus FEUERER, Helmholtz Junior Research Group Immune Tolerance (D100) E-mail

Dr. Thorsten FEYERABEND, Division of Cellular Immunology (D110) E-mail

PD Dr. Karsten GÜLOW, Division of Immunogenetics (D030) E-mail

Prof. Dr. Peter KRAMMER, Division of Immunogenetics (D030) E-mail

Prof. Dr. Bruno KYEWSKI, Division of Developmental Immunology (D090) E-mail

PD Dr. Frank MOMBURG, Division of Translational Immunology (D015) and NCT E-mail

Dr. Wolfram OSEN: now with Research Program 'G'

Prof. Dr. Hans-Reimer RODEWALD, Division of Cellular Immunology (D110) E-mail

PD Dr. Reinhard SCHWARTZ-ALBIEZ, Division of Translational Immunology (D015) E-mail

Dr. Ana STOJANOVIC, Boveri Junior Research Group Innate Immunity (D080) E-mail

Prof. Dr. Hedda WARDEMANN, Division of B Cell Immunology (D130) E-mail

Dr. Heiko WEYD, Division of Immunogenetics (D030) E-mail

Dr. Dr. Amir ABDOLLAHI, Junior Research Group Molecular Radiooncology (E210) E-mail

 

Prof. Dr. Peter BACHERT, Division of Medical Physics in Radiology (E020) E-mail

Dr. Mark BANGERT, Division of Medical Physics in Radiation Oncology (E040) E-mail

Dr. Sebastian BICKELHAUPT, Division of Radiology (E010) E-mail

Dr. Jens CARDINALE, Molecular Imaging Group, Division of Medical Physics in Radiology (E020) E-mail

Dr. Peter HÄRING, Division of Medical Physics in Radiation Oncology (E040) E-mail

Dr. Jürgen JENNE, Clinical Cooperation Unit Radiation Oncology (E050) E-mail

Dr. Dorde KOMLJENOVIC, Molecular Imaging Group, Division of Medical Physics in Radiology (E020) E-mail

Dr. Tristan KUDER, Division of Medical Physics in Radiology (E020) E-mail

Dr. Jan KUNTZ, Division of Medical Physics in Radiology (E020) E-mail

Prof. Dr. Mark E. LADD, Division of Medical Physics in Radiology (E020) E-mail

Dr. Frederik LAUN, Division of Medical Physics in Radiology (E020) E-mail

Dr. Florian MAIER, Division of Medical Physics in Radiology (E020) E-mail

Prof. Dr. Uwe OELFKE, Division of Medical Physics in Radiation Oncology (E040) E-mail

Dr. Jörg PETER, Division of Medical Physics in Radiology (E020) E-mail

Dr. Stefan SAWALL, Division of Medical Physics in Radiology (E020) E-mail

Dr. Silke ULRICH, Division of Medical Physics in Radiation Oncology (E040) E-mail

Dr. Marco BINDER, Division of Virus-associated Carcinogenesis (F170) E-mail


Prof. Dr. Henri-Jacques DELECLUSE, Division of Pathogenesis of Virus Associated Tumors (F100) E-mail

Dr. habil. Christiane DINSART, Division of Tumor Virology (F010) E-mail

Dr. Dirk GRIMM, CellNetworks Research Group Virus Host Interactions, Bioquant, University of Heidelberg E-Mail

Prof. Dr. Mathias HEIKENWÄLDER, Division of Chronic Inflammation and Cancer (F180) E-mail

Dr. Kai HOFMANN, Division of Chronic Inflammation and Cancer (F180) E-mail

Prof. Dr. Martin LÖCHELT, Division of Molecular Diagnostics of Oncogenic Infections (F020) E-mail

PD Dr. Antonio MARCHINI, Division of Tumor Virology (F010) E-mail

Prof. Dr. Martin MÜLLER, Research Group Tumorvirus-Specific Vaccination Strategies (F035) E-mail

Dr. Jürg NÜESCH, Division of Tumor Virology (F010) E-mail

Dr. Michael PAWLITA, Division of Molecular Diagnostics of Oncogenic Infections (F020) E-mail

PD Dr. Dr. Angelika RIEMER, Junior Research Group Immunotherapy and -prevention (F130) E-mail

Prof. Dr. Jean ROMMELAERE, Division of Tumor Virology (F010) E-mail

Dr. Tim WATERBOER, Division of Molecular Diagnostics of Oncogenic Infections (F020) E-mail

Dr. Claudia BALL, Division of Translational Oncology (G100) and NCT E-mail


Dr. Cynthia BARTHOLOMÄ, Division of Translational Oncology (G100) and NCT E-mail

Prof. Dr. Stefan EICHMÜLLER, Research Group GMP and T Cell Therapy (G182) Contact Form

Dr. Dr. Christine ENGELAND, Division of Translational Oncology (G100) and NCT E-mail

Prof. Dr. Stefan FRÖHLING, Division of Translational Oncology (G100) and NCT E-mail

Dr. Richard GABRIEL, Division of Translational Oncology (G100) and NCT E-mail

Prof. Dr. Hanno GLIMM, Division of Translational Oncology (G100) and NCT E-mail

Dr. Nikolas GUNKEL, Research Group Cancer Drug Development (G404) E-mail

Dr. Friederike HERBST, Division of Translational Oncology (G100) and NCT E-mail

Prof. Dr. Ingrid HERR, Molecular OncoSurgery Group, Heidelberg University Hospital E-mail (Secretary)

PD Dr. Jochen HESS, DKFZ Junior Group Molecular Mechanisms of Head and Neck Tumors (G405), NCT, and Heidelberg University Hospital E-mail

Prof. Dr. Christof von KALLE, Division of Translational Oncology (G100), Director NCT & Translational Oncology Section E-mail

PD Dr. Stephanie LAUFS, Division of Translational Oncology (G100) and NCT E-mail

Dr. Mona MALZ, Research Group Cancer Drug Development (G404) E-mail

Prof. Dr. Rienk OFFRINGA, Division of Molecular Oncology of Gastrointestinal Tumors (G180) and DKFZ-Bayer Immunotherapeutics Lab E-mail

Dr. Christiane OPITZ, DKFZ Junior Group Brain Cancer Metabolism (G161) E-mail

Dr. Wolfram OSEN, Research Group GMP and T Cell Therapy (G182) Contact Form

Dr. Isabel POSCHKE, Division of Molecular Oncology of Gastrointestinal Tumors (G180) E-mail

Dr. phil. Christoph SCHICKARDT, DASYMED: Big Data in Systems Medicine, NCT E-mail

Dr. Manfred SCHMIDT, Division of Translational Oncology (G100) and NCT E-mail

Prof. Dr. Claudia SCHOLL, Research Group Apllied Functional Genomics (G102) and NCT E-mail

Dr. Björn TEWS, CHS Junior Research Group Molecular Mechanisms of Tumor Cell Invasion (V077) E-mail

Prof. Dr. Viktor UMANSKY, Clinical Cooperation Unit for Dermato-Oncology (G300) E-mail

Prof. Dr. Dr. Guy UNGERECHTS, Division of Translational Oncology (G100) and NCT E-mail

Dr. Michael VOLKMAR, Division of Molecular Oncology of Gastrointestinal Tumors (G180) E-mail

How to become a Major Cancer Biology Faculty Member?

If you are DKFZ scientist or cooperative partner and wish to actively contribute to our study program by, e.g., giving lectures or tutorials, by organizing (part of) a HP-F practical, please contact the Coordinator, Prof. Ilse Hofmann, to discuss how your offer can be integrated to the program. We are always happy to welcome new active contributors!

In certain cases, teaching activities at the Bachelor level can also be honored by becoming a Major Cancer Biology faculty member.

to top